BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 3447443)

  • 21. Extracorporeal removal of uremic toxins: can we still do better?
    Eloot S; Ledebo I; Ward RA
    Semin Nephrol; 2014 Mar; 34(2):209-27. PubMed ID: 24780474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A bench to bedside view of uremic toxins.
    Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J;
    J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of dialysis membranes on the convective transport of middle molecules.
    De Francisco AL; Gordillo J; Cotorruelo JG; Ruiz L; Gonzalez M; Morales P; Arias M
    Int J Artif Organs; 1986 Nov; 9(6):421-6. PubMed ID: 3818117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental model for studies of continuous peritoneal'dialysis in uremic rabbits.
    Gotloib L; Crassweller P; Rodella H; Oreopoulos DG; Zellerman G; Ogilvie R; Husdan H; Brandes L; Vas S
    Nephron; 1982; 31(3):254-9. PubMed ID: 7121671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The anglerfish and uremic toxins.
    Lowenstein J
    FASEB J; 2011 Jun; 25(6):1781-5. PubMed ID: 21622695
    [No Abstract]   [Full Text] [Related]  

  • 26. [The role of dialysis membranes in elimination of uremic toxins].
    Grzeszczak W; Zukowska-Szczechowska E; Rutkowski B
    Przegl Lek; 1996; 53(5):439-42. PubMed ID: 8754410
    [No Abstract]   [Full Text] [Related]  

  • 27. Aluminum an uremic toxin.
    D'Haese PC; Van de Vyver FL; Lamberts LV; De Broe ME
    Adv Exp Med Biol; 1987; 223():89-96. PubMed ID: 3447454
    [No Abstract]   [Full Text] [Related]  

  • 28. Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.
    Smeby LC; Jörstad S; Wideröe TE; Svartaas TM
    Artif Organs; 1981; 4 Suppl():104-9. PubMed ID: 7295075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is new in uremic toxicity?
    Vanholder R; Van Laecke S; Glorieux G
    Pediatr Nephrol; 2008 Aug; 23(8):1211-21. PubMed ID: 18324423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Uremic Toxins and their Relation to Dialysis Efficacy.
    Clark WR; Dehghani NL; Narsimhan V; Ronco C
    Blood Purif; 2019; 48(4):299-314. PubMed ID: 31563911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using binding competitors of albumin to promote the removal of protein-bound uremic toxins in hemodialysis: Hope or pipe dream?
    Florens N; Yi D; Juillard L; Soulage CO
    Biochimie; 2018 Jan; 144():1-8. PubMed ID: 28987629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of substances of middle molecular mass in the body fluids of patients treated with intermittent peritoneal dialysis].
    Dukanović L; Petrović J
    Lijec Vjesn; 1982; 104(11-12):527-9. PubMed ID: 7187480
    [No Abstract]   [Full Text] [Related]  

  • 33. The middle molecule hypothesis in perspective.
    Babb AL; Ahmad S; Bergström J; Scribner BH
    Am J Kidney Dis; 1981 Jul; 1(1):46-50. PubMed ID: 6277187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dialysis in treatment of uremia: artificial kidney and peritoneal lavage.
    KOLFF WJ
    AMA Arch Intern Med; 1954 Jul; 94(1):142-60. PubMed ID: 13170850
    [No Abstract]   [Full Text] [Related]  

  • 35. Middle molecules re-examined.
    Henderson LW
    Nephron; 1978; 22(1-3):146-52. PubMed ID: 745634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactive carbonyl compounds as uremic toxins.
    Miyata T; Akhand AA; Kurokawa K; Nakashima I
    Contrib Nephrol; 2001; (133):71-80. PubMed ID: 11477755
    [No Abstract]   [Full Text] [Related]  

  • 37. Improved separation and quantification of the "middle molecule" b4-2 in uremia.
    Faguer P; Man NK; Cueille G; Di Giulio S; Funck-Brentano JL
    Clin Chem; 1983 Apr; 29(4):703-7. PubMed ID: 6831703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From uremic toxin retention to removal by convection: do we know enough?
    Vanholder R; Meert N; Schepers E; Glorieux G
    Contrib Nephrol; 2008; 161():125-131. PubMed ID: 18451668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular free amino acids in uremic patients as influenced by amino acid supply.
    Bergström J; Fürst P; Norée LO; Vinnars E
    Kidney Int Suppl; 1975 Feb; (3):345-8. PubMed ID: 1057709
    [No Abstract]   [Full Text] [Related]  

  • 40. Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane.
    Lesaffer G; De Smet R; Lameire N; Dhondt A; Duym P; Vanholder R
    Nephrol Dial Transplant; 2000 Jan; 15(1):50-7. PubMed ID: 10607767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.